WORK Medical Technology Group (WOK) Competitors $0.78 0.00 (-0.23%) Closing price 08/1/2025 03:55 PM EasternExtended Trading$0.77 -0.01 (-1.06%) As of 08/1/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock WOK vs. DXR, TMDIF, PYPD, MODD, NEPH, POCI, COCH, VVOS, DRIO, and FEMYShould you be buying WORK Medical Technology Group stock or one of its competitors? The main competitors of WORK Medical Technology Group include Daxor (DXR), Titan Medical (TMDIF), PolyPid (PYPD), Modular Medical (MODD), Nephros (NEPH), Precision Optics (POCI), Envoy Medical (COCH), Vivos Therapeutics (VVOS), DarioHealth (DRIO), and Femasys (FEMY). These companies are all part of the "medical equipment" industry. WORK Medical Technology Group vs. Its Competitors Daxor Titan Medical PolyPid Modular Medical Nephros Precision Optics Envoy Medical Vivos Therapeutics DarioHealth Femasys Daxor (NASDAQ:DXR) and WORK Medical Technology Group (NASDAQ:WOK) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership. Is DXR or WOK more profitable? Company Net Margins Return on Equity Return on Assets DaxorN/A N/A N/A WORK Medical Technology Group N/A N/A N/A Do insiders & institutionals hold more shares of DXR or WOK? 1.3% of Daxor shares are held by institutional investors. 59.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation & earnings, DXR or WOK? Daxor has higher earnings, but lower revenue than WORK Medical Technology Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaxorN/AN/AN/AN/AN/AWORK Medical Technology Group$11.51M3.81-$3.49MN/AN/A Does the media favor DXR or WOK? In the previous week, Daxor's average media sentiment score of 0.00 equaled WORK Medical Technology Group'saverage media sentiment score. Company Overall Sentiment Daxor Neutral WORK Medical Technology Group Neutral Do analysts recommend DXR or WOK? Daxor currently has a consensus target price of $25.00, indicating a potential upside of 164.55%. Given Daxor's stronger consensus rating and higher possible upside, research analysts plainly believe Daxor is more favorable than WORK Medical Technology Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00WORK Medical Technology Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryDaxor beats WORK Medical Technology Group on 5 of the 6 factors compared between the two stocks. Get WORK Medical Technology Group News Delivered to You Automatically Sign up to receive the latest news and ratings for WOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WOK vs. The Competition Export to ExcelMetricWORK Medical Technology GroupMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.93M$6.76B$5.49B$9.52BDividend YieldN/A1.32%4.73%4.09%P/E RatioN/A20.9428.7823.81Price / Sales3.8154.12372.2066.04Price / CashN/A20.5035.4557.96Price / Book0.704.468.275.54Net Income-$3.49M$174.54M$3.25B$259.28M7 Day Performance-6.33%-5.27%-3.70%-4.64%1 Month Performance8.72%-3.94%4.34%4.41%1 Year PerformanceN/A8.26%25.90%17.95% WORK Medical Technology Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WOKWORK Medical Technology GroupN/A$0.78-0.2%N/AN/A$43.93M$11.51M0.00226DXRDaxorN/A$9.18+2.0%$25.00+172.3%+16.0%$44.43MN/A0.0037TMDIFTitan MedicalN/A$0.38+2.8%N/A+934.6%$43.37M$17.63M-0.3050Gap DownPYPDPolyPid2.2861 of 5 stars$3.76+0.3%$11.80+213.8%-6.6%$38.31MN/A-0.8780MODDModular Medical0.4917 of 5 stars$0.70+0.1%N/A-53.0%$37.98MN/A-1.3720NEPHNephros1.7341 of 5 stars$3.51-1.7%$5.00+42.5%+52.6%$37.21M$14.16M50.1530News CoverageUpcoming EarningsPOCIPrecision Optics0.2066 of 5 stars$4.80-1.2%N/A-23.8%$36.82M$19.10M-5.3980Positive NewsCOCHEnvoy Medical1.9376 of 5 stars$1.61flat$9.25+474.5%-37.2%$34.34M$212K-1.1734News CoveragePositive NewsEarnings ReportGap UpVVOSVivos Therapeutics0.7156 of 5 stars$5.50+1.1%$4.82-12.4%+138.7%$32.40M$15.03M-3.18160Analyst UpgradeShort Interest ↑Gap DownDRIODarioHealth1.8671 of 5 stars$0.70-0.7%$2.00+185.6%-47.1%$31.14M$27.04M-1.25200Upcoming EarningsFEMYFemasys2.7852 of 5 stars$0.88-0.7%$8.67+889.9%-27.5%$28.48M$1.63M-0.9630 Related Companies and Tools Related Companies Daxor Alternatives Titan Medical Alternatives PolyPid Alternatives Modular Medical Alternatives Nephros Alternatives Precision Optics Alternatives Envoy Medical Alternatives Vivos Therapeutics Alternatives DarioHealth Alternatives Femasys Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WOK) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WORK Medical Technology Group LTD Please log in to your account or sign up in order to add this asset to your watchlist. Share WORK Medical Technology Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WOK Stock Alerts